Vulvovaginal Atrophy
Also known as: Vulvo-vaginal Atrophy / Vulvo Vaginal Atrophy / Atrophy;Vaginal / Vaginal Atrophy / Atrophic vulvovaginitis / Vulvovaginitis atrophy / Vulvovaginitis atrophic / Atrophic vulvovaginitis (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB01395 | Drospirenone | A progestin used in oral contraceptive pills for the prevention of pregnancy and other conditions. |
| DB00783 | Estradiol | An estrogenic steroid used to treat vasomotor symptoms of vulvar and vaginal atrophy in menopause, hypoestrogenism, prevention of postmenopausal osteoporosis, treatment of breast cancer, and advanced androgen-dependent carcinoma of the prostate. |
| DB04573 | Estriol | A weak estrogen used to treat vaginal dryness and estrogen deficiency conditions, such as vaginitis and vulvar itching. |
| DB00655 | Estrone | An estrogen used to treat perimenopausal and postmenopausal symptoms. |
| DB00603 | Medroxyprogesterone acetate | A progestin used as a contraceptive and in the treatment of secondary amenorrhea, abnormal uterine bleeding, pain from endometriosis, endometrial and renal carcinomas, paraphilia in males, and GnRH-dependent precocious puberty. |
| DB00717 | Norethisterone | A synthetic second-generation progestin used for contraception, prevention of endometrial hyperplasia in hormone replacement therapy, and in the treatment of other hormone-mediated illnesses such as endometriosis. |
| DB12487 | Promestriene | A synthetic estrogen applied topically for the treatment of vulvovaginal atrophic symptoms and to speed wound healing following vulvovaginal surgery or trauma (e.g. post-partum). |